We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Garlic Raises Hydrogen Sulfide Levels, Relaxing Arteries

By HospiMedica staff writers
Posted on 29 Oct 2007
A new study has found that the protective effect of garlic is closely linked to how much hydrogen sulfide (H2S) is produced from garlic compounds interacting with red blood cells (RBCs).

Researchers from the University of Alabama at Birmingham (UAB, USA) examined molecules in garlic called polysulfides and their ability to liberate H2S within cells. More...
They found that when fresh garlic was used at a concentration equal to eating two cloves, the interaction triggered RBCs to release H2S. This H2S production is supported by glucose-maintained cytosolic glutathione levels and is to a large extent reliant on reduced thiols in or on the RBC membrane.

The resulting increase in H2S production caused up to 72% vessel relaxation in rat arteries. The researchers found that H2S production from organic polysulfides was facilitated by allyl substituents and by increasing numbers of tethering sulfur atoms. The findings were published in the October 19, 2007, online edition of the journal Proceedings of the National Academy of Sciences (PNAS).

"When these garlic compounds are metabolized to H2S in the vascular system, the H2S targets membrane channels and causes smooth muscle cells to relax,” said lead author said David Kraus, Ph.D., an associate professor in the departments of environmental health sciences and biology. "So a garlic-rich diet has many good effects, and H2S may be the common mediator.”

H2S is a toxic, flammable gas responsible for the smell of rotten eggs. It's also produced naturally by the body in small amounts, and as age advances, H2S production dwindles. Exactly how H2S affords the cardiovascular system so much protection is not entirely clear.


Related Links:
University of Alabama at Birmingham

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.